News summarySEC EDGARNov 4, 2026, 12:00 PM
Summit Therapeutics 8-K (8.01, 9.01): other events
Summit Therapeutics filed a prospectus supplement to its automatic shelf registration statement and submitted Baker & Hostetler LLP’s opinion on the legality of the common shares covered by the supplement.